OSTEOPORE LIMITED — Director's Dealing 2023

Oct 4, 2023

==> picture [130 x 44] intentionally omitted <==

5 October 2023

ASX Market Announcements

Company Announcements Office ASX Limited

Dear Sir/Madam,

Appendix 3Y – Change of Director’s Interest Notice

As announced to the ASX on 12 May 2023, Osteopore Limited ( Company ) issued Performance Rights to Mr. Mark Leong, Professor Teoh Swee Hin and Mr. Daniel Ow (together, the Directors ) (or their respective nominees) under the Company’s employee securities incentive plan on 10 May 2023.

Please find attached Appendix 3Ys Change of Director’s Interest Notice for each of the Directors relating to the issue of the Performance Rights.

In relation to the late lodgement of the attached Appendix 3Ys, the Company advises that:

• The Appendix 3Ys were lodged late due to an administrative oversight. The Company arranged for the Appendix 3Ys to be lodged with ASX as soon as practicable upon the Company becoming aware of the oversight described above.

• The Company and its directors are aware of their obligations under ASX Listing Rules 3.19A and 3.19B.

• The Company considers that its current practices are adequate to ensure compliance with the relevant ASX Listing Rules. However, the Company intends to further review its procedures to identify and implement any potential improvements.

This announcement has been authorised by the Company Secretary, Kellie Davis.

==> picture [71 x 46] intentionally omitted <==

Kellie Davis Company Secretary

Osteopore Limited (ACN 630 538 957)│ASX:OSX│Level 5, 191 St Georges Terrace, Perth│+61 2 8072 1400│www.osteopore.com

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Osteopore Limited ABN 65 630 538 957

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the following the director for the purposes of section	information under listing rule 3.19A.2 and as agent for 205G of the Corporations Act.
Name of Director	Mark Leong
Date of last notice	7 July 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Mark Leong Mark Leong is a Director of Avalon Partners Pte Ltd.
Date of change		1. 10 May 2023 2. 10 May 2023 3. 10 May 2023 4. 10 May 2023 5. 10 May 2023
No. of securities held prior to change		Mark Leong 187,500 Fully paid ordinary shares 37,500 Listed Options
Class		1. Performance rights (Tranche A) 2. Performance rights (Tranche B) 3. Performance rights (Tranche C) 4. Performance rights (Tranche D) 5. Performance rights (Tranche E)
Number acquired		1. 1,000,000 2. 1,500,000 3. 1,750,000 4. 2,250,000 5. 2,750,000

Appendix 3Y Change of Director’s Interest Notice

Number disposed		Nil.
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation		1. 1,000,000 performance rights (Tranche A) issued for nil cash consideration as incentive pursuant to resolution 4(a) of the Notice of General Meeting dated 28 February 2023. 2. 1,500,000 performance rights (Tranche B) issued for nil cash consideration as incentive pursuant to resolution 4(a) of the Notice of General Meeting dated 28 February 2023. 3. 1,750,000 performance rights (Tranche C) issued for nil cash consideration as incentive pursuant to resolution 4(a) of the Notice of General Meeting dated 28 February 2023. 4. 2,250,000 performance rights (Tranche D) issued for nil cash consideration as incentive pursuant to resolution 4(a) of the Notice of General Meeting dated 28 February 2023. 5. 2,750,000 performance rights (Tranche E) issued for nil cash consideration as incentive pursuant to resolution 4(a) of the Notice of General Meeting dated 28 February 2023. Refer to the Notice of General Meeting dated 28 February 2023 for estimated valuation.
No. of securities held after change		Mark Leong 187,500 Fully paid ordinary shares 37,500 Listed Options Mark Leong 1,000,000 performance rights (Tranche A) 1,500,000 performance rights (Tranche B) 1,750,000 performance rights (Tranche C) 2,250,000 performance rights (Tranche D) 2,750,000 performance rights (Tranche E)
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Issue of Director Performance Rights as approved by shareholders at the Company’s General Meeting held on 31 March 2023.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 2

3476-8750-0327, v. 1

Appendix 3Y Change of Director’s Interest Notice

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

3476-8750-0327, v. 1

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Osteopore Limited ABN 65 630 538 957

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the following the director for the purposes of section	information under listing rule 3.19A.2 and as agent for 205G of the Corporations Act.
Name of Director	Teoh Swee Hin
Date of last notice	28 April 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		-
Date of change		1. 10 May 2023 2. 10 May 2023 3. 10 May 2023 4. 10 May 2023 5. 10 May 2023
No. of securities held prior to change		Teoh Swee Hin Nil Citicorp Nominees Pty Limited, as custodian for Professor Teoh Swee Hin 8,912,886 Fully paid ordinary shares 1,782,577 Listed Options

Appendix 3Y Change of Director’s Interest Notice

Class	1. Performance rights (Tranche A) 2. Performance rights (Tranche B) 3. Performance rights (Tranche C) 4. Performance rights (Tranche D) 5. Performance rights (Tranche E)
Number acquired	1. 100,000 2. 150,000 3. 175,000 4. 225,000 5. 275,000
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	1. 100,000 performance rights (Tranche A) issued for nil cash consideration as incentive pursuant to resolution 4(b) of the Notice of General Meeting dated 28 February 2023. 2. 150,000 performance rights (Tranche B) issued for nil cash consideration as incentive pursuant to resolution 4(b) of the Notice of General Meeting dated 28 February 2023. 3. 175,000 performance rights (Tranche C) issued for nil cash consideration as incentive pursuant to resolution 4(b) of the Notice of General Meeting dated 28 February 2023. 4. 225,000 performance rights (Tranche D) issued for nil cash consideration as incentive pursuant to resolution 4(b) of the Notice of General Meeting dated 28 February 2023. 5. 275,000 performance rights (Tranche E) issued for nil cash consideration as incentive pursuant to resolution 4(b) of the Notice of General Meeting dated 28 February 2023. Refer to the Notice of General Meeting dated 28 February 2023 for estimated valuation.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 2

3445-6615-1719, v. 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change		Teoh Swee Hin 100,000 performance rights (Tranche A) 150,000 performance rights (Tranche B) 175,000 performance rights (Tranche C) 225,000 performance rights (Tranche D) 275,000 performance rights (Tranche E) Citicorp Nominees Pty Limited, as custodian for Professor Teoh Swee Hin 8,912,886 Fully paid ordinary shares 1,782,577 Listed Options
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Issue of Director Performance Rights as approved by shareholders at the Company’s General Meeting held on 31 March 2023.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

3445-6615-1719, v. 1

Appendix 3Y Change of Director’s Interest Notice

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 4

3445-6615-1719, v. 1

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Osteopore Limited ABN 65 630 538 957

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the following the director for the purposes of section	information under listing rule 3.19A.2 and as agent for 205G of the Corporations Act.
Name of Director	Daniel Ow
Date of last notice	13 October 2021

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest		Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.		-
Date of change		1. 10 May 2023 2. 10 May 2023 3. 10 May 2023 4. 10 May 2023 5. 10 May 2023
No. of securities held prior to change		Daniel Ow Nil

Appendix 3Y Change of Director’s Interest Notice

Class	1. Performance rights (Tranche A) 2. Performance rights (Tranche B) 3. Performance rights (Tranche C) 4. Performance rights (Tranche D) 5. Performance Rights (Tranche E)
Number acquired	1. 100,000 2. 150,000 3. 175,000 4. 225,000 5. 275,000
Number disposed	Nil
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	1. 100,000 performance rights (Tranche A) issued for nil cash consideration as incentive pursuant to resolution 4(c) of the Notice of General Meeting dated 28 February 2023. 2. 150,000 performance rights (Tranche B) issued for nil cash consideration as incentive pursuant to resolution 4(c) of the Notice of General Meeting dated 28 February 2023. 3. 175,000 performance rights (Tranche C) issued for nil cash consideration as incentive pursuant to resolution 4(c) of the Notice of General Meeting dated 28 February 2023. 4. 225,000 performance rights (Tranche D) issued for nil cash consideration as incentive pursuant to resolution 4(c) of the Notice of General Meeting dated 28 February 2023. 5. 275,000 performance rights (Tranche E) issued for nil cash consideration as incentive pursuant to resolution 4(c) of the Notice of General Meeting dated 28 February 2023. Refer to the Notice of General Meeting dated 28 February 2023 for estimated valuation.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 2

3446-6674-9479, v. 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change		Daniel Ow 100,000 performance rights (Tranche A) 150,000 performance rights (Tranche B) 175,000 performance rights (Tranche C) 225,000 performance rights (Tranche D) 275,000 performance rights (Tranche E)
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back		Issue of Director Performance Rights as approved by shareholders at the Company’s General Meeting held on 31 March 2023.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above No traded during a[+] closed period where prior written clearance was required?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

3446-6674-9479, v. 1

Appendix 3Y Change of Director’s Interest Notice

If so, was prior written clearance provided to allow the trade to proceed during this period?	N/A
If prior written clearance was provided, on what date was this provided?	N/A

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 4

3446-6674-9479, v. 1